Hospira
Overview
Hospira is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™ by developing, manufacturing and marketing products that improve the productivity, safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories in April 2004, Hospira has a 70-year history of service to the hospital industry. In February 2007, Hospira acquired Mayne Pharma Limited to become the world leader in specialty generic injectable pharmaceuticals. Through its offering of high-quality, lower-cost alternatives to proprietary medications, Hospira continues to help reduce the overall costs of healthcare – to improve both the affordability of care for patients and the financial strength of the global healthcare system. The company also is a pioneer in providing innovative solutions to improve patient and healthcare worker safety. Its portfolio includes one of the industry's broadest lines of generic acute-care and oncology injectables, and integrated solutions for medication management and infusion therapy. Hospira now has more than 1,100 employees in Australia. With more than 85 active drug substances in its portfolio, Hospira is the leading supplier of injectable generic pharmaceuticals to Australian hospitals.
Number of employees: >14,000
Main business focus/
Listing by sector:
- Medical Devices - Drug delivery devices
- Oncology
- Infectious Diseases
Competitive Advantages
Hospira has a leading position in the manufacture and supply of a broad range of hospital products including:
�� Specialty injectables (including generic acute-care and oncology injectables, intensive-care proprietary pharmaceuticals, as well as proprietary delivery systems such as the iSecure™ syringe, a pre-filled, ready-to-use, disposable syringe)
�� Medication management systems (including electronic infusion pumps and the Hospira MedNet® software system)
�� Infusion therapy solutions/supplies (including the VisIV™ next-generation container)
�� Critical care devices
Partnering Opportunities
Hospira offers third-party contract development and manufacturing for injectable pharmaceuticals including biopharmaceuticals, and also offers this service for oral pharmaceuticals. These services leverage Hospira's expertise in pharmaceutical manufacturing. For more information about biopharmaceutical contract development and manufacturing see the entry under Hospira Adelaide.Hospira can also offer global or regional opportunities for commercialization partnership for pharmaceuticals through its global distribution and marketing network and has a wide variety of commercial partnerships world wide.
Contact Details
| Address | 1 Lexia Place |
|---|---|
| City/Suburb | Mulgrave |
| State | Victoria |
| customerservice.au@hospira.com | |
| Phone | 1300 046 774 |
| Fax | 1800 644 810 |
| Website | http://www.hospira.com.au |
